MYCOBACTERIUM TUBERCULOSIS;INDUCED MACROPHAGE SIGNALLING
MYCOBACTERIUM TUBERCULOSIS;INDUCED MACROPHAGE SIGNALLING
批准号:
6183444
负责人:
Joel D. Ernst
金额:
$23.3万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 2002-08-31
中文摘要
描述(改编自申请人的摘要):结核病(TB)是
世界上最常见的致命传染病,仍然是一个威胁,
美国的健康状况。虽然改善了病例发现和获得
治疗已经降低了美国结核病的发病率,
结核病控制和治疗的改善取决于更好地了解
结核病的发病机制。巨噬细胞对于抵抗感染是必不可少的,
并且是结核病发病机制的核心。当巨噬细胞遇到大多数
细菌会吞噬并杀死它们相反,巨噬细胞吞噬,
但别杀了M结核病,即使它们被IFN γ刺激。
PI实验室最近的实验表明,一个意味着M。
肺结核逃避巨噬细胞杀伤的方法是阻断信号
由干扰素γ启动的转导途径。PI发现,
M.结核病阻碍了几种巨噬细胞
对IFN γ的反应,并发现这种信号传导的中断
减少IFN γ应答基因的转录激活,
信号通路中的一步。M.结核病巨噬细胞感染的原因
释放一种或多种抑制IFN γ信号传导的可溶性因子,
未感染的巨噬细胞TGF-β、IL-4、IL-6、IL-10和前列腺素E2
不能解释这种现象。PI建议识别组件
分枝启动IFN γ信号传导抑制的结核病。一
待检验假设是巨噬细胞被M.结核
诱导一个阻遏物,该阻遏物结合启动子区域中的特异性DNA元件,
干扰素γ应答基因。最后,PI将纯化可溶性
存在于受感染细胞的条件培养基中的因子,其抑制
未感染巨噬细胞中的干扰素γ信号传导。拟议的实验
将提高对结核病发病机制的认识,
提供必要的见解,以便制定有效的办法,
保护性免疫反应结核
英文摘要
DESCRIPTION(Adapted from the applicant's abstract): Tuberculosis (TB) is the
most common fatal infectious disease in the world, and remains a threat to
health in the United States. While improved case finding and access to
treatment have reduced the incidence of TB in the United States, further
improvements in TB control and therapy depend on better understanding of the
pathogenesis of TB. Macrophages are essential for defense against infections,
and are central to the pathogenesis of TB. When macrophages encounter most
bacteria, they phagocytose and kill them. In contrast, macrophages phagocytose,
but do not kill M. tuberculosis, even when they are stimulated with IFN gamma.
Recent experiments in the PI's laboratory reveal that one means that M.
tuberculosis uses to evade killing by macrophages is to block the signal
transduction pathway initiated by interferon gamma. The PI has found that
infection of macrophages with M. tuberculosis blocks several macrophage
responses to IFN gamma, and has found that this disruption of signalling
reduces transcriptional activation of IFN gamma-responsive genes at a distal
step in the signalling pathway. M. tuberculosis infection of macrophages causes
release of one or more soluble factors that inhibit IFN gamma signaling in
uninfected macrophages. TGF-beta, IL-4, IL-6, IL-10, and prostaglandin E2
cannot account for this phenomenon. The PI proposes to identify the component
of M. tuberculosis that initiates the inhibition of IFN gamma signaling. One
hypothesis to be tested is that infection of macrophages by M. tuberculosis
induces a repressor that binds specific DNA elements in the promoter region of
interferon gamma-responsive genes. Finally, the PI will purify the soluble
factor present in the conditioned medium from infected cells that inhibits
interferon gamma signaling in uninfected macrophages. The proposed experiments
will enhance the understanding of the pathogenesis of tuberculosis, and will
provide insight essential for developing effective approaches to enhancing the
protective immune response to M. tuberculosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
-
批准号:10735075
-
项目类别:
-
资助金额:$85.51万
-
财政年份:2023
-
负责人:Joel D. Ernst
-
依托单位:
Functional dynamics of TB granuloma architecture
-
批准号:10593978
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2022
-
负责人:Joel D. Ernst
-
依托单位:
Functional dynamics of TB granuloma architecture
-
批准号:10358264
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2022
-
负责人:Joel D. Ernst
-
依托单位:
Live Imaging of Immunity to M. tuberculosis
-
批准号:10326395
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2021
-
负责人:Joel D. Ernst
-
依托单位:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
-
批准号:10005738
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2020
-
负责人:Joel D. Ernst
-
依托单位:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
-
批准号:10194362
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2020
-
负责人:Joel D. Ernst
-
依托单位:
Antigen export in M. tuberculosis evasion of CD4 T cells
-
批准号:9318402
-
项目类别:
-
资助金额:$72.01万
-
财政年份:2016
-
负责人:Joel D. Ernst
-
依托单位:
Epitope-specific T cell activation to complement TB immunity and vaccine efficacy
-
批准号:8867688
-
项目类别:
-
资助金额:$50.25万
-
财政年份:2014
-
负责人:Joel D. Ernst
-
依托单位:
Initiation of the Immune Response to M. tuberculosis
-
批准号:8678398
-
项目类别:
-
资助金额:$50.59万
-
财政年份:2014
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:8678383
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2013
-
负责人:Joel D. Ernst
-
依托单位:
Training Program in Immunology and Inflammation
-
批准号:8495260
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2012
-
负责人:Joel D. Ernst
-
依托单位:
Training Program in Immunology and Inflammation
-
批准号:8663183
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2012
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:8414848
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:8602804
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:7800614
-
项目类别:
-
资助金额:$41.35万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis antigen diversity
-
批准号:8084140
-
项目类别:
-
资助金额:$67.45万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:8011522
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
-
批准号:8207965
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis antigen diversity
-
批准号:8280454
-
项目类别:
-
资助金额:$64.76万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
Mycobacterium tuberculosis antigen diversity
-
批准号:8476981
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2010
-
负责人:Joel D. Ernst
-
依托单位:
国内基金
海外基金
鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
-
批准号:31760442
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2017
-
负责人:许倩
-
依托单位: